[HTML][HTML] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

[HTML][HTML] Health Benefits of Coffee Consumption for Cancer and Other Diseases and Mechanisms of Action

S Safe, J Kothari, A Hailemariam, S Upadhyay… - International journal of …, 2023 - mdpi.com
Coffee is one of the most widely consumed beverages worldwide, and epidemiology studies
associate higher coffee consumption with decreased rates of mortality and decreased rates …

Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance

M San Luciano, CM Tanner, C Meng… - Movement …, 2020 - Wiley Online Library
Background The penetrance of leucine rich repeat kinase 2 (LRRK2) mutations is
incomplete and may be influenced by environmental and/or other genetic factors …

Effect modification between genes and environment and Parkinson's disease risk

MT Periñán, K Brolin, S Bandres‐Ciga… - Annals of …, 2022 - Wiley Online Library
Parkinson's disease (PD) is a complex neurodegenerative condition in which genetic and
environmental factors interact to contribute to its etiology. Remarkable progress has been …

Epigenetic clock acceleration is linked to age at onset of Parkinson's disease

X Tang, P Gonzalez‐Latapi, C Marras… - Movement …, 2022 - Wiley Online Library
Background Aging is the strongest risk factor for Parkinson's disease (PD), which is a
clinically heterogeneous movement disorder with highly variable age at onset. DNA …

[HTML][HTML] Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach

E Menozzi, AHV Schapira, F Blandini… - Current Neurology and …, 2023 - Springer
Abstract Purpose of Review Genetic variants in GBA1 and LRRK2 genes are the commonest
genetic risk factor for Parkinson disease (PD); however, the preclinical profile of GBA1 and …

[HTML][HTML] Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease

C Gabbert, IR König, T Lüth, B Kolms, M Kasten… - Journal of …, 2022 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder. Genetic modifiers,
environmental factors and gene–environment interactions have been found to modify PD …

[HTML][HTML] Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

JF Chen, MA Schwarzschild - Parkinsonism & related disorders, 2020 - Elsevier
The adenosine A 2A receptor is a major target of caffeine, the most widely used
psychoactive substance worldwide. Large epidemiological studies have long shown …

[HTML][HTML] Age at onset as stratifier in idiopathic Parkinson's disease–effect of ageing and polygenic risk score on clinical phenotypes

L Pavelka, A Rauschenberger, Z Landoulsi… - npj Parkinson's …, 2022 - nature.com
Several phenotypic differences observed in Parkinson's disease (PD) patients have been
linked to age at onset (AAO). We endeavoured to find out whether these differences are due …

[HTML][HTML] Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism

VG Chittoor-Vinod, RJ Nichols, B Schüle - International Journal of …, 2021 - mdpi.com
Missense mutations in the LRRK2 gene were first identified as a pathogenic cause of
Parkinson's disease (PD) in 2004. Soon thereafter, a founder mutation in LRRK2, p. G2019S …